Area of research
Immunology · Cancer Research
Research interest
Research interests include Phagocytosis and Immune Regulation, Cancer, Hypoxia, and Metabolism, Immune cells in cancer, and Angiogenesis and VEGF in Cancer.
Prolonged inhibition of intratumoral mast cells enhances efficacy of low‐dose antiangiogenic therapy
AML Treatment By the AXL Inhibitor Bemcentinib in Combination with Cytarabine Shows Clinical Efficacy Related to TNFα and Cytotoxic Immune Cells: A Single-Cell Translational Study from the BGBC003 Trial
Regulation of bone homeostasis by MERTK and TYRO3
AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms
Blockade of Myeloid-Derived Suppressor Cell Expansion with All- <i>Trans</i> Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy